Results emerging from the review by Sherwin et al. showed that chronic activation of the renin-angiotensin-aldosterone system (RAAS) may be implicated in the pathogenesis of DR and glaucoma, thus suggesting a possible new therapeutic target on which to base new studies' intervention (105). The gene discussed is REN; the disease is glaucoma.